Bio-Rad Laboratories Return on Investment 2010-2022 | BIO.B

Current and historical return on investment (ROI) values for Bio-Rad Laboratories (BIO.B) over the last 10 years.
Bio-Rad Laboratories ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2022-03-31 $0.53B $11.38B 4.09%
2021-12-31 $0.49B $13.68B 3.82%
2021-09-30 $0.56B $15.34B 4.70%
2021-06-30 $0.51B $11.61B 4.99%
2021-03-31 $0.44B $10.62B 4.77%
2020-12-31 $0.41B $9.89B 5.07%
2020-09-30 $0.30B $8.84B 4.17%
2020-06-30 $0.24B $7.37B 3.87%
2020-03-31 $0.25B $6.31B 4.18%
2019-12-31 $0.23B $5.77B 4.06%
2019-09-30 $-0.06B $5.57B -1.07%
2019-06-30 $-0.08B $5.92B -1.48%
2019-03-31 $-0.09B $5.30B -1.78%
2018-12-31 $-0.10B $4.46B -2.08%
2018-09-30 $0.18B $5.34B 3.85%
2018-06-30 $0.18B $5.08B 4.40%
2018-03-31 $0.14B $4.92B 3.70%
2017-12-31 $0.12B $3.37B 3.65%
2017-09-30 $0.04B $3.28B 1.32%
2017-06-30 $0.03B $3.25B 0.99%
2017-03-31 $0.06B $3.14B 1.82%
2016-12-31 $0.06B $3.01B 1.84%
2016-09-30 $0.14B $3.14B 4.50%
2016-06-30 $0.14B $3.05B 4.77%
2016-03-31 $0.16B $2.98B 5.47%
2015-12-31 $0.17B $2.92B 5.92%
2015-09-30 $0.16B $2.87B 5.79%
2015-06-30 $0.16B $2.80B 5.93%
2015-03-31 $0.16B $2.63B 6.22%
2014-12-31 $0.15B $2.62B 5.67%
2014-09-30 $0.15B $2.61B 5.70%
2014-06-30 $0.15B $2.69B 5.58%
2014-03-31 $0.15B $2.67B 5.78%
2013-12-31 $0.17B $2.62B 6.29%
2013-09-30 $0.19B $2.56B 6.91%
2013-06-30 $0.23B $2.80B 8.19%
2013-03-31 $0.25B $2.76B 9.10%
2012-12-31 $0.26B $2.75B 9.99%
2012-09-30 $0.29B $2.67B 11.22%
2012-06-30 $0.30B $2.59B 11.81%
2012-03-31 $0.29B $2.57B 11.76%
2011-12-31 $0.31B $2.48B 12.57%
2011-09-30 $0.29B $2.43B 12.09%
2011-06-30 $0.29B $2.46B 12.47%
2011-03-31 $0.29B $2.35B 13.07%
2010-12-31 $0.28B $2.27B 13.35%
2010-09-30 $0.26B $2.16B 12.69%
2010-06-30 $0.25B $2.04B 12.61%
2010-03-31 $0.24B $2.04B 12.27%
2009-12-31 $0.23B $2.02B 12.51%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $14.907B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $163.597B 9.95
QIAGEN (QGEN) Netherlands $10.865B 17.15
Biohaven Pharmaceutical Holding (BHVN) United States $10.248B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.228B 0.00
Arcus Biosciences (RCUS) United States $1.901B 48.18
Emergent Biosolutions (EBS) United States $1.599B 6.85
Myovant Sciences (MYOV) United Kingdom $1.236B 0.00
Zymeworks (ZYME) Canada $0.320B 0.00
Gelesis Holdings (GLS) United States $0.114B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
Ambrx Biopharma (AMAM) United States $0.103B 0.00
SQZ Biotechnologies (SQZ) United States $0.087B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00